Company

SGX Pharmaceuticals, Inc.

SGX Pharmaceuticals develops treatments for cancer and other diseases.

About

Founded in 1998 in San Diego, US, SGX Pharmaceuticals focused on pharmaceutical research and development. Eli Lilly and Company Limited acquired it in July 2008 for USD 66.20 mn. Michael Grey served as CEO.

3Funding rounds

11Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in